Cargando…

Incidence and predictors of excessive warfarin anticoagulation in patients with atrial fibrillation—The EWA study

Vitamin K antagonist warfarin is widely used in clinical practice and excessive anticoagulation is a well-known complication of this therapy. Little is known about permanent and temporary predictors for severe overanticoagulation. The aim of this study was to investigate the occurrence and predictin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jaakkola, Samuli, Nuotio, Ilpo, Kiviniemi, Tuomas O., Virtanen, Raine, Issakoff, Melina, Airaksinen, K. E. Juhani
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5398615/ https://www.ncbi.nlm.nih.gov/pubmed/28426737 http://dx.doi.org/10.1371/journal.pone.0175975

Ejemplares similares

Association of Heart Rate With Troponin Levels Among Patients With Symptomatic Atrial Fibrillation
por: Pouru, Jussi-Pekka, et al.
Publicado: (2020)

Inadequate oral anticoagulation with warfarin in women with cerebrovascular event and history of atrial fibrillation: the FibStroke study
por: Bah, Aissa, et al.
Publicado: (2021)

Etiology of Minor Troponin Elevations in Patients with Atrial Fibrillation at Emergency Department–Tropo-AF Study
por: Jaakkola, Samuli, et al.
Publicado: (2019)

Frequency of cardioversions as an additional risk factor for stroke in atrial fibrillation – the FinCV-4 study
por: Jaakkola, Samuli, et al.
Publicado: (2022)

Stroke as the First Manifestation of Atrial Fibrillation
por: Jaakkola, Jussi, et al.
Publicado: (2016)

Advanced interatrial block predicts ineffective cardioversion of atrial fibrillation: a FinCV2 cohort study
por: Relander, Arto, et al.
Publicado: (2021)

Prediction of ineffective elective cardioversion of atrial fibrillation: a retrospective multi-center patient cohort study
por: Hellman, Tapio, et al.
Publicado: (2017)

Reliability of pulse palpation in the detection of atrial fibrillation in an elderly population
por: Jaakkola, Jussi, et al.
Publicado: (2017)

Association of CHA2DS2-VASc Score with Long-Term Incidence of New-Onset Atrial Fibrillation and Ischemic Stroke after Myocardial Infarction
por: Jaakkola, Samuli, et al.
Publicado: (2022)

Self-detection of atrial fibrillation in an aged population: three-year follow-up of the LietoAF intervention study
por: Jaakkola, Jussi, et al.
Publicado: (2017)

Clinical assessment of a non-invasive wearable MEMS pressure sensor array for monitoring of arterial pulse waveform, heart rate and detection of atrial fibrillation
por: Kaisti, Matti, et al.
Publicado: (2019)

The impact of mental health conditions on oral anticoagulation therapy and outcomes in patients with atrial fibrillation: A systematic review and meta-analysis
por: Teppo, Konsta, et al.
Publicado: (2021)

Subtype of atrial fibrillation and the outcome of transcatheter aortic valve replacement: The FinnValve Study
por: Jaakkola, Jussi, et al.
Publicado: (2020)

Real‐life experience with non‐vitamin K antagonist oral anticoagulants versus warfarin in patients undergoing elective cardioversion of atrial fibrillation
por: Itäinen‐Strömberg, Saga, et al.
Publicado: (2020)

Synergic impact of oral anticoagulation control and renal function in determining major adverse events in atrial fibrillation patients undergoing percutaneous coronary intervention: insights from the AFCAS registry
por: Proietti, Marco, et al.
Publicado: (2017)

Mechanocardiography in the Detection of Acute ST Elevation Myocardial Infarction: The MECHANO-STEMI Study
por: Koivisto, Tero, et al.
Publicado: (2022)

Preoperative paroxysmal atrial fibrillation predicts high cardiovascular mortality in patients undergoing surgical aortic valve replacement with a bioprosthesis: CAREAVR study
por: Nissinen, Maunu, et al.
Publicado: (2020)

Warfarin doses for anticoagulation therapy in elderly patients with chronic atrial fibrillation
por: de Padua Mansur, Antonio, et al.
Publicado: (2012)

Survey of the use of warfarin and the newer anticoagulant dabigatran in patients with atrial fibrillation
por: Choi, Jiyoon C, et al.
Publicado: (2014)

Mechanocardiography-Based Measurement System Indicating Changes in Heart Failure Patients during Hospital Admission and Discharge
por: Koivisto, Tero, et al.
Publicado: (2022)

Veterans Perceptions of Satisfaction and Convenience with Anticoagulants for Atrial Fibrillation: Warfarin versus Direct Oral Anticoagulants
por: Mull, Hillary J, et al.
Publicado: (2020)

How to Optimize Cardioversion of Atrial Fibrillation
por: Airaksinen, K. E. Juhani
Publicado: (2022)

Renal Impairment and Prognosis of Patients with Atrial Fibrillation Undergoing Coronary Intervention - The AFCAS Trial
por: Lahtela, Heli M., et al.
Publicado: (2015)

Direct Oral Anticoagulant Adherence of Patients With Atrial Fibrillation Transitioned from Warfarin
por: Pundi, Krishna N., et al.
Publicado: (2021)

Safety of direct oral anticoagulants compared to warfarin in cirrhotic patients with atrial fibrillation
por: Yoo, Seo Yeon, et al.
Publicado: (2022)

Stability of High‐Quality Warfarin Anticoagulation in a Community‐Based Atrial Fibrillation Cohort: The Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study
por: Dallalzadeh, Liane O., et al.
Publicado: (2016)

The effect of mental health conditions on the use of oral anticoagulation therapy in patients with atrial fibrillation: the FinACAF study
por: Jaakkola, Jussi, et al.
Publicado: (2021)

Warfarin anticoagulation in hemodialysis patients with atrial fibrillation: comparison of nephrologist-led and anticoagulation clinic-led management
por: Bahbahani, Hamad, et al.
Publicado: (2018)

Association of income and educational levels on initiation of oral anticoagulant therapy in patients with incident atrial fibrillation: A Finnish nationwide cohort study
por: Teppo, Konsta, et al.
Publicado: (2022)

Mental Health Conditions and Nonpersistence of Direct Oral Anticoagulant Use in Patients With Incident Atrial Fibrillation: A Nationwide Cohort Study
por: Teppo, Konsta, et al.
Publicado: (2022)

Control of Anticoagulation Therapy in Patients with Atrial Fibrillation Treated with Warfarin: A Study from the Chinese Atrial Fibrillation Registry
por: Liang, Hai-Feng, et al.
Publicado: (2019)

Atrial fibrillation bleeding risk and prediction while treated with direct oral anticoagulants in warfarin‐naïve or warfarin‐experienced patients
por: Perino, Alexander C., et al.
Publicado: (2022)

Impact of anaemia on clinical outcome in patients with atrial fibrillation undergoing percutaneous coronary intervention: insights from the AFCAS registry
por: Puurunen, Marja, et al.
Publicado: (2014)

Cost-Effectiveness of Anticoagulation in Patients with Nonvalvular Atrial Fibrillation with Edoxaban Compared to Warfarin in Germany
por: Krejczy, Martin, et al.
Publicado: (2015)

Direct Oral Anticoagulants Versus Warfarin in Patients With Atrial Fibrillation and Valve Replacement or Repair
por: Mentias, Amgad, et al.
Publicado: (2022)

Lower dose direct oral anticoagulation or warfarin in atrial fibrillation. Which one is the best when time on therapeutic range information is available?
por: Luojus, A, et al.
Publicado: (2023)

An interview with Ewa Czochrowska
por: Czochrowska, Ewa
Publicado: (2018)

Ten Years of EWAS
por: Wei, Siyu, et al.
Publicado: (2021)

Rural-urban differences in the initiation of oral anticoagulant therapy in patients with incident atrial fibrillation: A Finnish nationwide cohort study
por: Teppo, Konsta, et al.
Publicado: (2022)

Interatrial block, P terminal force or fragmented QRS do not predict new-onset atrial fibrillation in patients with severe chronic kidney disease
por: Hellman, Tapio, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_9gb1bcjoqkoj0o5ul3s3ldc3kt